Unsuspected leiomyosarcoma

Treatment with a gonadotropin-releasing hormone analogue

William R. Meyer, Allan R. Mayer, Michael P. Diamond, Maria L. Carcangiu, Peter E. Schwartz, Alan H. DeCherney

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

We present a case of a 46-year-old woman evaluated for abnormal uterine bleeding and an enlarged uterus, with normal endometrial sampling. Three months of leuprolide acetate injections resulted in a nonenlarging uterus and resolution of iron deficiency anemia and menorrhagia. Intraoperative examination suggested leiomyosarcoma, which was confirmed by postoperative permanent histologic sections. Residual uterine sarcomatous disease was confirmed on reexploration. Similar cases will continue to raise arguments against conservative hormonal intervention in the perimenopausal woman with an enlarged uterus. As the gynecologist gains familiarity with the use of gonadotropinreleasing hormone analogue therapy in the treatment of myomatous uteri, the criteria for hysterectomy will become less rigid and the potential for delay in the diagnosis and treatment of sarcomatous disease will become more common. Physicians must be cognizant of this potential complication of conservative therapy of leiomyomata uteri.

Original languageEnglish
Pages (from-to)529-532
Number of pages4
JournalObstetrics and Gynecology
Volume75
Issue number3
Publication statusPublished - 1990

Fingerprint

Leiomyosarcoma
Gonadotropin-Releasing Hormone
Uterus
Uterine Diseases
Leuprolide
Therapeutics
Menorrhagia
Iron-Deficiency Anemias
Uterine Hemorrhage
Leiomyoma
Hysterectomy
Hormones
Physicians
Injections

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Meyer, W. R., Mayer, A. R., Diamond, M. P., Carcangiu, M. L., Schwartz, P. E., & DeCherney, A. H. (1990). Unsuspected leiomyosarcoma: Treatment with a gonadotropin-releasing hormone analogue. Obstetrics and Gynecology, 75(3), 529-532.

Unsuspected leiomyosarcoma : Treatment with a gonadotropin-releasing hormone analogue. / Meyer, William R.; Mayer, Allan R.; Diamond, Michael P.; Carcangiu, Maria L.; Schwartz, Peter E.; DeCherney, Alan H.

In: Obstetrics and Gynecology, Vol. 75, No. 3, 1990, p. 529-532.

Research output: Contribution to journalArticle

Meyer, WR, Mayer, AR, Diamond, MP, Carcangiu, ML, Schwartz, PE & DeCherney, AH 1990, 'Unsuspected leiomyosarcoma: Treatment with a gonadotropin-releasing hormone analogue', Obstetrics and Gynecology, vol. 75, no. 3, pp. 529-532.
Meyer WR, Mayer AR, Diamond MP, Carcangiu ML, Schwartz PE, DeCherney AH. Unsuspected leiomyosarcoma: Treatment with a gonadotropin-releasing hormone analogue. Obstetrics and Gynecology. 1990;75(3):529-532.
Meyer, William R. ; Mayer, Allan R. ; Diamond, Michael P. ; Carcangiu, Maria L. ; Schwartz, Peter E. ; DeCherney, Alan H. / Unsuspected leiomyosarcoma : Treatment with a gonadotropin-releasing hormone analogue. In: Obstetrics and Gynecology. 1990 ; Vol. 75, No. 3. pp. 529-532.
@article{d884ca3f19ad46339648cf20b97533bc,
title = "Unsuspected leiomyosarcoma: Treatment with a gonadotropin-releasing hormone analogue",
abstract = "We present a case of a 46-year-old woman evaluated for abnormal uterine bleeding and an enlarged uterus, with normal endometrial sampling. Three months of leuprolide acetate injections resulted in a nonenlarging uterus and resolution of iron deficiency anemia and menorrhagia. Intraoperative examination suggested leiomyosarcoma, which was confirmed by postoperative permanent histologic sections. Residual uterine sarcomatous disease was confirmed on reexploration. Similar cases will continue to raise arguments against conservative hormonal intervention in the perimenopausal woman with an enlarged uterus. As the gynecologist gains familiarity with the use of gonadotropinreleasing hormone analogue therapy in the treatment of myomatous uteri, the criteria for hysterectomy will become less rigid and the potential for delay in the diagnosis and treatment of sarcomatous disease will become more common. Physicians must be cognizant of this potential complication of conservative therapy of leiomyomata uteri.",
author = "Meyer, {William R.} and Mayer, {Allan R.} and Diamond, {Michael P.} and Carcangiu, {Maria L.} and Schwartz, {Peter E.} and DeCherney, {Alan H.}",
year = "1990",
language = "English",
volume = "75",
pages = "529--532",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Unsuspected leiomyosarcoma

T2 - Treatment with a gonadotropin-releasing hormone analogue

AU - Meyer, William R.

AU - Mayer, Allan R.

AU - Diamond, Michael P.

AU - Carcangiu, Maria L.

AU - Schwartz, Peter E.

AU - DeCherney, Alan H.

PY - 1990

Y1 - 1990

N2 - We present a case of a 46-year-old woman evaluated for abnormal uterine bleeding and an enlarged uterus, with normal endometrial sampling. Three months of leuprolide acetate injections resulted in a nonenlarging uterus and resolution of iron deficiency anemia and menorrhagia. Intraoperative examination suggested leiomyosarcoma, which was confirmed by postoperative permanent histologic sections. Residual uterine sarcomatous disease was confirmed on reexploration. Similar cases will continue to raise arguments against conservative hormonal intervention in the perimenopausal woman with an enlarged uterus. As the gynecologist gains familiarity with the use of gonadotropinreleasing hormone analogue therapy in the treatment of myomatous uteri, the criteria for hysterectomy will become less rigid and the potential for delay in the diagnosis and treatment of sarcomatous disease will become more common. Physicians must be cognizant of this potential complication of conservative therapy of leiomyomata uteri.

AB - We present a case of a 46-year-old woman evaluated for abnormal uterine bleeding and an enlarged uterus, with normal endometrial sampling. Three months of leuprolide acetate injections resulted in a nonenlarging uterus and resolution of iron deficiency anemia and menorrhagia. Intraoperative examination suggested leiomyosarcoma, which was confirmed by postoperative permanent histologic sections. Residual uterine sarcomatous disease was confirmed on reexploration. Similar cases will continue to raise arguments against conservative hormonal intervention in the perimenopausal woman with an enlarged uterus. As the gynecologist gains familiarity with the use of gonadotropinreleasing hormone analogue therapy in the treatment of myomatous uteri, the criteria for hysterectomy will become less rigid and the potential for delay in the diagnosis and treatment of sarcomatous disease will become more common. Physicians must be cognizant of this potential complication of conservative therapy of leiomyomata uteri.

UR - http://www.scopus.com/inward/record.url?scp=0025017284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025017284&partnerID=8YFLogxK

M3 - Article

VL - 75

SP - 529

EP - 532

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -